Nikki Laine has been taking the weight-loss drug Mounjaro for just over three weeks and has described it as "life-changing" ...

This Feature (BMJ 2025;388:q2636, doi:10.1136/bmj.q2636, published 3 February 2025) stated that the NICE guidance on tirzepatide was still in draft form. In fact ...

"Each injection is painful." In the recent study, researchers explored if the diabetes and obesity drug tirzepatide(the active ingredient in Zepbound and Mounjaro) could improve CGL, as it improves ...

CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...

The primary endpoint of the Phase 2 BMT-801 clinical trial is to demonstrate the safety and efficacy of co-administration of bremelanotide with tirzepatide on reducing body weight. Patients were ...

In the SURMOUNT-1 trial in people with obesity or overweight with weight-related complications, 72-week tirzepatide treatment led to clinically meaningful body weight and blood pressure reduction.

Manufactured by Eli Lilly and Company, both Mounjaro and Zepbound contain the active ingredient tirzepatide. Tirzepatide is similar to semaglutide, which is used in medications like Ozempic, Rybelsus, ...

40,667 people played the daily Crossword recently. Can you solve it faster than others?40,667 people played the daily Crossword recently. Can you solve it faster than others?

Zepbound (tirzepatide) is only available on prescription for people with obesity, or those with overweight. Learn how to get Zepbound online, in-person, and through the drug’s manufacturer ...

Com­pound­ing fa­cil­i­ty ProRx Phar­ma­cy Net­work has re­ceived an FDA warn­ing let­ter over is­sues with its semaglu­tide and tirzepatide pro­duc­tion.